A Phase II Study Of rhuMAb VEGF (BEVACIZUMAB) In Patients With Hepatocellular Carcinoma Receiving Chemoembolization
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Bevacizumab (Primary) ; Cisplatin; Doxorubicin liposomal; Mitomycin
- Indications Liver cancer
- Focus Biomarker; Therapeutic Use
- 10 May 2012 Actual patient number 31 added as reported by ClinicalTrials.gov.
- 10 May 2012 Actual end date (February 2012) added as reported by ClinicalTrials.gov.
- 10 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.